187 related articles for article (PubMed ID: 10760769)
21. Benefit-risk balance of reoperation for persistent medullary thyroid cancer.
Machens A; Dralle H
Ann Surg; 2013 Apr; 257(4):751-7. PubMed ID: 23023200
[TBL] [Abstract][Full Text] [Related]
22. Role of FNA cytology and immunochemistry in the diagnosis and management of medullary thyroid carcinoma: report of six cases and review of the literature.
Bhanot P; Yang J; Schnadig VJ; Logroño R
Diagn Cytopathol; 2007 May; 35(5):285-92. PubMed ID: 17427218
[TBL] [Abstract][Full Text] [Related]
23. [Surgical management of upper mediastinal lymph nodes metastases from thyroid carcinoma].
Li ZJ; Miao XX; Tang PZ; Xu ZG; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):145-7. PubMed ID: 16750024
[TBL] [Abstract][Full Text] [Related]
24. Lymph node involvement in macroscopic medullary thyroid carcinoma.
Tamagnini P; Iacobone M; Sebag F; Marcy M; De Micco C; Henry JF
Br J Surg; 2005 Apr; 92(4):449-53. PubMed ID: 15672437
[TBL] [Abstract][Full Text] [Related]
25. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
26. Medullary thyroid carcinoma with nodular goiter carries an excellent prognosis.
Xu L; Wang WB; Zhao YP; Zhang TP; Liao Q; Chen G; Zhou L; Shu H
J Surg Oncol; 2012 Aug; 106(2):169-73. PubMed ID: 22354558
[TBL] [Abstract][Full Text] [Related]
27. Contralateral cervical and mediastinal lymph node metastasis in medullary thyroid cancer: systemic disease?
Machens A; Holzhausen HJ; Dralle H
Surgery; 2006 Jan; 139(1):28-32. PubMed ID: 16364714
[TBL] [Abstract][Full Text] [Related]
28. Lymph node dissection in the lateral neck for completion in central node-positive papillary thyroid cancer.
Machens A; Hauptmann S; Dralle H
Surgery; 2009 Feb; 145(2):176-81. PubMed ID: 19167972
[TBL] [Abstract][Full Text] [Related]
29. Biological relevance of medullary thyroid microcarcinoma.
Machens A; Dralle H
J Clin Endocrinol Metab; 2012 May; 97(5):1547-53. PubMed ID: 22399508
[TBL] [Abstract][Full Text] [Related]
30. Review analysis of medullary carcinoma of the thyroid: a 15-year Indian experience.
Dorairajan N; Siddharth D; Kanna S
Int Surg; 2006; 91(3):162-7. PubMed ID: 16845858
[TBL] [Abstract][Full Text] [Related]
31. Detection of disseminated medullary thyroid carcinoma cells in cervical lymph nodes by cytokeratin 20 reverse transcription-polymerase chain reaction.
Weber T; Amann K; Weckauf H; Lacroix J; Weitz J; Schönfuss T; Hölting T; Klar E; Herfarth C; von Knebel Doeberitz M
World J Surg; 2002 Feb; 26(2):148-52. PubMed ID: 11865340
[TBL] [Abstract][Full Text] [Related]
32. [Clinical evaluation of management of superior mediastinal metastasis from thyroid carcinoma with systemic superior mediastinal dissection via sternotomy approach: 12 cases report].
Zhang Q; Guo ZM; Fu JH; Zeng ZY; Chen FJ; Wei MW; Wu GH; Yang AK
Ai Zheng; 2004 Jul; 23(7):842-4. PubMed ID: 15248925
[TBL] [Abstract][Full Text] [Related]
33. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract][Full Text] [Related]
34. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
Cohen R; Campos JM; Salaün C; Heshmati HM; Kraimps JL; Proye C; Sarfati E; Henry JF; Niccoli-Sire P; Modigliani E
J Clin Endocrinol Metab; 2000 Feb; 85(2):919-22. PubMed ID: 10690910
[TBL] [Abstract][Full Text] [Related]
35. Pattern of nodal metastasis for primary and reoperative thyroid cancer.
Machens A; Hinze R; Thomusch O; Dralle H
World J Surg; 2002 Jan; 26(1):22-8. PubMed ID: 11898029
[TBL] [Abstract][Full Text] [Related]
36. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.
Franc S; Niccoli-Sire P; Cohen R; Bardet S; Maes B; Murat A; Krivitzky A; Modigliani E;
Clin Endocrinol (Oxf); 2001 Sep; 55(3):403-9. PubMed ID: 11589685
[TBL] [Abstract][Full Text] [Related]
37. The lymph node ratio as prognostic factor in node-positive breast cancer.
Voordeckers M; Vinh-Hung V; Van de Steene J; Lamote J; Storme G
Radiother Oncol; 2004 Mar; 70(3):225-30. PubMed ID: 15064006
[TBL] [Abstract][Full Text] [Related]
38. The Delphian lymph node in thyroid cancer.
Isaacs JD; Lundgren CI; Sidhu SB; Sywak MS; Edhouse PJ; Delbridge LW
Ann Surg; 2008 Mar; 247(3):477-82. PubMed ID: 18376193
[TBL] [Abstract][Full Text] [Related]
39. Surgical treatment of sporadic medullary thyroid carcinoma: strategy and outcome.
Misso C; Calzolari F; Puxeddu E; Lucchini R; Monacelli M; D'Ajello F; Giammartino C; D'Ajello M; Ragusa M; Avenia N
G Chir; 2008; 29(11-12):475-8. PubMed ID: 19068183
[TBL] [Abstract][Full Text] [Related]
40. Long term prognosis of medullary thyroid carcinoma in 39 patients.
Voutilainen PE; Multanen M; Haapiainen RK; Haglund CH; Sane T; Sivula AH
Ann Chir Gynaecol; 2000; 89(4):292-7. PubMed ID: 11204961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]